CHMP Agenda, page-10

If my memory serves me correctly, at the AGM one of the directors mentioned that he was also a director of another bio tech company which also has a device awaiting approval from the EMA . It relates to a stent (which is already approved and in use) but has been improved with a teflon like coating. Evidently this is being treated as a completely new device and CE Mark approval has also been dragging on for more than two years. Any other members who were at the AGM may like to confirm or correct me on this.